Quavonlimab
Product Specifications
UNSPSC Description
Quavonlimab (MK-1308) is a novel anti-CTLA-4 antibody[1].
Target Antigen
CTLA-4
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/quavonlimab.html
Purity
99.0
Solubility
10 mM in DMSO
Smiles
[Quavonlimab]
References & Citations
[1]Perets R, et al. Safety and efficacy of quavonlimab, a novel anti-CTLA-4 antibody (MK-1308), in combination with pembrolizumab in first-line advanced non-small-cell lung cancer. Ann Oncol. 2021;32(3):395-403.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P99809/Quavonlimab-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P99809/Quavonlimab-SDS-MedChemExpress.pdf
Clinical Information
Phase 2
CAS Number
2254059-25-9
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS2134759-01 0.1 mL
PE Linked Monoclonal Antibody to Activin A Receptor Type II A (ACVR2A)
Ask
View Details MBS2134759-02 0.2 mL
PE Linked Monoclonal Antibody to Activin A Receptor Type II A (ACVR2A)
Ask
View Details MBS2134759-03 0.5 mL
PE Linked Monoclonal Antibody to Activin A Receptor Type II A (ACVR2A)
Ask
View Details 
MBS2134759-04 1 mL
PE Linked Monoclonal Antibody to Activin A Receptor Type II A (ACVR2A)
Ask
View Details